Leaflet ANASTROZOL CIPLA 1mg film-coated tablets

Product code:
W61023001
Quantity:
10
Indicated for:
breast cancer
Route of administration:
oral
Substance:
anastrozole (aromatase inhibitor)
ATC
L02BG03 — Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors
Anastrozole is a medication used in the treatment of hormone-dependent breast cancer in postmenopausal women. It belongs to the class of aromatase inhibitors and works by blocking the aromatase enzyme, which is responsible for converting androgens into estrogens. By reducing estrogen levels, anastrozole slows the growth of tumors that depend on this hormone.

Anastrozole is taken orally, usually once daily, and treatment may last for several years depending on the stage of the disease and the patient's response.

Common side effects include hot flashes, joint pain, fatigue, nausea, and osteoporosis. In rare cases, severe adverse reactions such as bone fractures or liver function impairment may occur.

Patients taking anastrozole should undergo regular monitoring for bone density and liver function. Additionally, the medication is not indicated for premenopausal women or those who are pregnant. Anastrozole is an effective option for managing hormone-dependent breast cancer, contributing to improved patient outcomes.

General data about ANASTROZOL CIPLA 1mg

Substance:
anastrozole
Date of latest medicines list:
01-01-2015
Product code:
W61023001
Concentration:
1mg
Pharmaceutical form:
film-coated tablets
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.